Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study

BACKGROUND: Hepatitis B virus (HBV) infections are responsible for the development of chronic hepatitis in 400 million people worldwide. Currently, no consensus exists as to when treatment should be initiated for pediatric patients.

Saved in:
Bibliographic Details
Main Authors: Yasmine Yousef, Kathie Béland, Emmanuel Mas, Pascal Lapierre, Dorothée Bouron Dal Soglio, Fernando Alvarez
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2012/928912
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561717974925312
author Yasmine Yousef
Kathie Béland
Emmanuel Mas
Pascal Lapierre
Dorothée Bouron Dal Soglio
Fernando Alvarez
author_facet Yasmine Yousef
Kathie Béland
Emmanuel Mas
Pascal Lapierre
Dorothée Bouron Dal Soglio
Fernando Alvarez
author_sort Yasmine Yousef
collection DOAJ
description BACKGROUND: Hepatitis B virus (HBV) infections are responsible for the development of chronic hepatitis in 400 million people worldwide. Currently, no consensus exists as to when treatment should be initiated for pediatric patients.
format Article
id doaj-art-8b89843fc69e4ca7bdfcff8a438d4f96
institution Kabale University
issn 0835-7900
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-8b89843fc69e4ca7bdfcff8a438d4f962025-02-03T01:24:25ZengWileyCanadian Journal of Gastroenterology0835-79002012-01-0126742943510.1155/2012/928912Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year StudyYasmine Yousef0Kathie Béland1Emmanuel Mas2Pascal Lapierre3Dorothée Bouron Dal Soglio4Fernando Alvarez5Division of Gastroenterology, Hepatology and Nutrition, CHU Sainte-Justine, Montreal, Quebec, CanadaDivision of Gastroenterology, Hepatology and Nutrition, CHU Sainte-Justine, Montreal, Quebec, CanadaDivision of Gastroenterology, Hepatology, Nutrition and Diabetology, Children’s Hospital, Toulouse, FranceDivision of Gastroenterology, Hepatology and Nutrition, CHU Sainte-Justine, Montreal, Quebec, CanadaDivision of Pathology, CHU Sainte-Justine, CanadaDivision of Gastroenterology, Hepatology and Nutrition, CHU Sainte-Justine, Montreal, Quebec, CanadaBACKGROUND: Hepatitis B virus (HBV) infections are responsible for the development of chronic hepatitis in 400 million people worldwide. Currently, no consensus exists as to when treatment should be initiated for pediatric patients.http://dx.doi.org/10.1155/2012/928912
spellingShingle Yasmine Yousef
Kathie Béland
Emmanuel Mas
Pascal Lapierre
Dorothée Bouron Dal Soglio
Fernando Alvarez
Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study
Canadian Journal of Gastroenterology
title Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study
title_full Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study
title_fullStr Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study
title_full_unstemmed Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study
title_short Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study
title_sort predictive factors of lamivudine treatment success in a hepatitis b virus infected pediatric cohort a 10 year study
url http://dx.doi.org/10.1155/2012/928912
work_keys_str_mv AT yasmineyousef predictivefactorsoflamivudinetreatmentsuccessinahepatitisbvirusinfectedpediatriccohorta10yearstudy
AT kathiebeland predictivefactorsoflamivudinetreatmentsuccessinahepatitisbvirusinfectedpediatriccohorta10yearstudy
AT emmanuelmas predictivefactorsoflamivudinetreatmentsuccessinahepatitisbvirusinfectedpediatriccohorta10yearstudy
AT pascallapierre predictivefactorsoflamivudinetreatmentsuccessinahepatitisbvirusinfectedpediatriccohorta10yearstudy
AT dorotheebourondalsoglio predictivefactorsoflamivudinetreatmentsuccessinahepatitisbvirusinfectedpediatriccohorta10yearstudy
AT fernandoalvarez predictivefactorsoflamivudinetreatmentsuccessinahepatitisbvirusinfectedpediatriccohorta10yearstudy